Holen Sie sich die Stockscreener-App
12.62
2.47%
-0.32
Handel nachbörslich:
12.50
-0.12
-0.95%
Schlusskurs vom Vortag:
$12.94
Offen:
$12.72
24-Stunden-Volumen:
2.12M
Relative Volume:
1.79
Marktkapitalisierung:
$964.79M
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-4.3668
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
+5.34%
1M Leistung:
+34.54%
6M Leistung:
+11.98%
1J Leistung:
-48.43%
1-Tages-Spanne:
$12.28
$13.19
1-Wochen-Bereich:
$11.37
$13.23
52-Wochen-Spanne:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Vergleichen Sie NRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
12.62 | 1.31B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Insider Sell: Houte Van Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
Nurix therapeutics CFO van Houte sells $78,931 in stock By Investing.com - Investing.com Canada
Full technical analysis of Nurix Therapeutics Inc. stockDividend Hike & Stepwise Swing Trade Plans - newser.com
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Nurix (NASDAQ: NRIX) to present NX-5948 data in CLL and Waldenström at ASH - Stock Titan
Analyzing Nurix Therapeutics Inc. with risk reward ratio chartsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
What to expect from Nurix Therapeutics Inc. in the next 30 daysStop Loss & Fast Momentum Entry Tips - newser.com
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 Setups & Verified Technical Signals - newser.com
Is Nurix Therapeutics Inc. stock ready for breakout2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBuy Signal & Momentum Based Trading Ideas - newser.com
Signal strength of Nurix Therapeutics Inc. stock in tech scannersWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Nurix Therapeutics Inc. stock daily chart insightsJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
Can Nurix Therapeutics Inc. recover in the next quarterExit Point & Fast Exit and Entry Trade Guides - newser.com
Will Nurix Therapeutics Inc. stock deliver consistent dividendsWeekly Trend Report & Daily Technical Forecast Reports - newser.com
Visual trend scoring systems applied to Nurix Therapeutics Inc.Weekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com
Why Nurix Therapeutics Inc. stock is seen as undervalued2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com
How institutional ownership impacts Nurix Therapeutics Inc. stockOptions Play & High Accuracy Swing Trade Signals - newser.com
Is Nurix Therapeutics Inc. building a consolidation baseAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
How moving averages guide Nurix Therapeutics Inc. tradingDollar Strength & AI Enhanced Execution Alerts - newser.com
Can Nurix Therapeutics Inc. stock hit record highs againTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
What technical charts say about Nurix Therapeutics Inc. stockJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com
Will Nurix Therapeutics Inc. stock go up soonJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 3,130 Shares - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) Insider Sells $52,313.60 in Stock - MarketBeat
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - MSN
Will Nurix Therapeutics Inc. bounce back from current supportPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock - Black Hills Pioneer
Applying chart zones and confluence areas to Nurix Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - newser.com
Nurix Therapeutics CFO van Houte sells $40k in shares By Investing.com - Investing.com UK
Nurix therapeutics CSO Hansen sells $52k in shares By Investing.com - Investing.com UK
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):